When we evaluated the expression of exhaustion markers (CTLA4, LAG3, PD1, and TIM3) in BC patients, we found that CD4+ and CD8+ T cells in exhibit a significant increase in TIM3 and LAG3 expression compared with HD. The gene discussed is HAVCR2; the disease is breast cancer.